US Patent Issued to The Regents of the University of California on Jan. 20 for "Transcription active complex targeting cancer drug from viral protein sequence" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,840, issued on Jan. 20, was assigned to The Regents of the University of California (Oakland, Calif.).

"Transcription active complex targeting cancer drug from viral protein sequence" was invented by Yoshihiro Izumiya (Elk Grove, Calif.) and Michiko Shimoda (Sacramento, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating a disease involving inappropriate or excessive cell proliferation or for treating an inflammatory condition or an autoimmune disease by inhibiting MYC activity in cells such as MYC-dependent cancer cells."

The patent was filed on Oct. 21, 2021, under Application...